Agenda EURLSSG-Meeting

Friday 9th Dec. 2011 8:30 - 17:00 h

Epidemiological and experimental data

Marco Zucconi, Milan, Italy
Karin Stiasny-Kolster, Marburg, Germany

Results from prospective cohort studies on RLS, with a focus on [ABSTRACT]
- RLS and mortality
- Incidence and risk factors of RLS
- Change in RLS symptoms and/or severity over time

Klaus Berger, Münster, Germany

RLS in a Georgian individuals with and without epilepsy – A questionnaire study [ABSTRACT]
Lia Maisuradze and Sofia Kasradze, Tbilisi, Georgia

Restless legs syndrome and epilepsy
Samson Khachatryan, Yerevan, Armenia

RLS severity symptoms in relation to environmental and habitual conditions - the Mediterranean example. Acronym: HappyFeet [ABSTRACT]
Georgios Hadjigeorgiou, Larissa, Greece

The A11 diencephalospinal pathway in non human primates is not dopaminergic

Imad Ghorayeb, Bordeaux, France

Skeletal muscle morphology in patients with RLS
Britta Wåhlin-Larsson, Örebro, Sweden

Effects of transcutaneous spinal direct current stimulation in patients with idiopathic RLS [ABSTRACT]
Cornelius Bachmann, Göttingen, Germany


Clinical Findings I

Magdolna Hornyak, Freiburg, Germany
Georgios Hadjigeorgiou, Larissa, Greece

Validation of a new interview method for the diagnosis of RLS augmentation (RLS-AUDI)
Heike Benes, Schwerin, Germany

Validation study of a patient-reported IRLS

Ralf Kohnen, Nuremberg, Germany

Experience with the Johns Hopkins Telephone Diagnostic Interview

Thomas Mitterling, Innsbruck, Austria

Occurence of periodic limb movements in primary insomnia
Michaela Sebert, Berlin, Germany

Periodic limb movements in sleep as a potential cardiovascular risk factor in hemodialysis patients: association to cardiac structure and function [ABSTRACT]
Christoforos Giannaki, Larissa, Greece

Subjective and objective measures of excessive daytime sleepiness in RLS
Hildegard Hidalgo, Zürich, Switzerland

- Discussion -

Clinical Findings II


Olli Polo, Turku, Finland
Rosalia Silvestri, Messina, Italy

Searching for silent strokes in magnetic resonance imaging of patients with RLS and Controls [ABSTRACT]
Raffaele Ferri, Troina, Italy

Iron and glutamate in RLS

Richard Allen, Baltimore, USA

Restless legs syndrome (RLS) in children: presenting symptoms
Al de Weerd, Zwolle, Netherlands

-Discussion -

Treatment Options:

Diego Garcia Borreguero, Madrid, Spain
Claudia Trenkwalder, Kassel, Germany

Change of psychosocial impairment during treatment of RLS: what can we learn from randomized controlled trials?
Hanna Scholz, Freiburg, Germany

Time course of response to intravenous iron in RLS
Magdolna Hornyak, Freiburg, Germany

Peripheral nerve compressions in the lower extremities aggravating RLS Severity - a new therapeutical option for selected patients [ABSTRACT]
Martin Raghunath, Munich/Frankfurt, Germany

Assessing the efficacy and safety of botulinum toxin type A in patients with RLS (unpublished data)
Imad Ghorayeb, Bordeaux, France

Overview on non-pharmacological interventions in RLS
Giorgos Sakkas, Larissa, Greece

Current Status of RLS in Finland
Markku Partinen, Espoo, Finland

State-of-the-art and other news

Juliane Winkelmann, Munich, Germany
Birgit Högl, Innsbruck, Austria

RLS name change: current plans - A report from the IRLSSG meeting September 2011 in Quebec
Diego Garcia Borreguero, Madrid, Spain

Update on genetics
Juliane Winkelmann, Munich, Germany

A unifying model of RLS:
2011 update
Olli Polo, Tampere, Finland

Development of the brain bank

Lilo Habersack, Munich, Germany


Agenda Workshop

Saturday 10th Dec. 2011 9:00 - 13:15 h


Chairpersons: Marco Zucconi, Italy and Raffaele Ferri, Italy


PLMS as a tool for the diagnosis of RLS and the evaluation of drug effects
Mauro Manconi, Switzerland

Do PLMW and SIT improve the specificity of PLMS for diagnosis and treatment effect evaluation in RLS?
Diego Garcia-Borreguero, Spain and Marco Zucconi, Italy

Do sleep macro- and microstructure add something to the diagnosis and treatment effect evaluation in RLS?
Raffaele Ferri, Italy

Is there a role for the pharmacologic test?
Karin Stiasny-Kolster, Germany

Role and limits of actigraphy?
Richard Allen, USA and Birgit Högl, Austria

Which is the role of peripheral nerve investigation for RLS diagnosis?
Cornelius Bachmann, Germany


RLS Diagnostic Index vs IRLSSG criteria and other questionnaires for the diagnosis of RLS
Heike Benes, Germany

IRLS, RLS-6 and other severity scales to measure the effect of treatment for RLS
Ralf Kohnen, Germany

Quality of life (QoL) and depression/anxiety symptom measures for the assessment of treatment in RLS
Jan Wesström, Sweden

Other subjective items/scales to test RLS complications or side effects (augmentation, impulsive control disorders, etc)
Rosalia Silvestri, Italy

Final Discussion